logo
Select company
Select metric
$ 22.07MNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
16
Sector
25
Industry
34
History
10
$ 2Close
$ 0.71 - $ 2.05 52-Week Range
Ticker Information

Ticker

IRD

Company Name

OPUS GENETICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

OPUS GENETICS INC - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IRD - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ 22.07M
3/31/2025$ 23.63M
12/31/2024$ 4.19M
9/30/2024$ 7.95M
6/30/2024$ 12.98M
3/31/2024$ 11.42M
12/31/2023$ 8.98M
9/30/2023$ 5.35M
6/30/2023$ 1.23M
3/31/2023$ 3.09M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • OPUS GENETICS INC's latest trailing twelve months (TTM) CF - Equity stands at $ 0.
  • Over the past 5 years, OPUS GENETICS INC's average CF - Equity has been $ 11.43M.
  • The median CF - Equity for OPUS GENETICS INC during this period was $ 10.2M
  • OPUS GENETICS INC reached its highest CF - Equity over the past 5 years at $ 29.8M.
  • The lowest CF - Equity recorded by OPUS GENETICS INC in the same timeframe $ 0

OPUS GENETICS INC's CF - Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Equity Benchmarks
CompanyCF - Equity
VRCA : VERRICA PHARMACEUTICALS INC $ 39.64MBRNS : BARINTHUS BIOTHERAPEUTICS PLC $ 1.3MEQ : EQUILLIUM INC $ 148KHYFT : MINDWALK HOLDINGS CORP $ 8.47MXLO : XILIO THERAPEUTICS INC $ 60.4MCUE : CUE BIOPHARMA INC $ 29.69MSRZN : SURROZEN INC $ 71.35MWHWK : WHITEHAWK THERAPEUTICS INC $ 94.48MOVID : OVID THERAPEUTICS INC $ 51KSEER : SEER INC $ -15.79M

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

IRD - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ 0

Minimum

Sep 30, 2020

$ 29.8M

Maximum

Mar 31, 2022

$ 11.43M

Average

$ 10.2M

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 113.43K with a standard deviation of $ 17.63M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.9K
min$ -60.59M
max$ 60.64M
average$ 113.43K
median$ 0
std$ 17.63M